Intraluminal thrombus enhances proteolysis in abdominal aortic aneurysms

Vascular

Volumn 14, Issue 1, 2006, Pages 9-16

  Carrell, Tom W G ^a   Burnand, Kevin G ^a   Booth, Nuala A ^b   Humphries, Julia ^a   Smith, Alberto ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; Fibrinolysis; Plasmin; Proteolysis; Thrombus

Indexed keywords

ALPHA 2 ANTIPLASMIN; GELATINASE B; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; THROMBOGENESIS;

AGED; AGED, 80 AND OVER; ANTIPLASMIN; AORTIC ANEURYSM, ABDOMINAL; ENZYME ACTIVATION; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 33745698070     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2006.00008     Document Type: Article

References (41)

1. Inzoli F, Boschetti F, Zappa M, et al. Biomechanical factors in abdominal aortic aneurysm rupture. Eur J Vasc Surg 1993;7: 667-74.
2. Thubrikar MJ, Robicsek F, Labrosse M, et al. Effect of thrombus on abdominal wall dilation and stress. J Cardiovasc Surg 2003; 44:67-77.
3. Wang DH, Makaroun MS, Webster MW, Vorp DA. Effect of intraluminal thrombus on wall stress in patient-specific models of abdominal aortic aneurysm. J Vasc Surg 2002;36:598-604.
4. Wang DH, Makaroun MS, Webster MW, Vorp DA. Mechanical properties and microstructure of intraluminal thrombus from abdominal aortic aneurysm. J Biomech Eng 2001;123:536-9.
5. Di Martino E, Mantero S, Inzoli F, et al. Biomechanics of abdominal aortic aneurysm in the presence of endoluminal thrombus: experimental characterisation and structural static computational analysis. Eur J Vasc Endovasc Surg 1998;15: 290-9.
6. Peattie RA, Asbury CL, Bluth EI, Riehle TJ. Steady flow in models of abdominal aortic aneurysms. Part II: wall stresses and their implication for in vivo thrombosis and rupture. J Ultrasound Med 1996;15:689-96.
7. Mower WR, Quinones WJ, Gambhir SS. Effect of intraluminal thrombus on abdominal aortic aneurysm wall stress. J Vasc Surg 1997;26:602-8.
8. Satta J, Laara E, Juvonen T. Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm [letter]. J Vasc Surg 1996;23:737-9.
9. Wolf YG, Thomas WS, Brennan FJ, et al. CT scanning findings associated with rapid expansion of abdominal aortic aneurysms. J Vasc Surg 1994;20:529-38.
10. Stenbaek J, Kalin B, Swedenborg J. Growth of thrombus may be a better predictor of rupture than diameter in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000; 20:466-9.
11. Cappeller WA, Engelmann H, Blechschmidt S, et al. Possible objectification of a critical maximum diameter for elective surgery in abdominal aortic aneurysms based on one- and three-dimensional ratios. J Cardiovasc Surg 1997;38:623-8.
12. Gregory AK, Yin NX, Capella J, et al. Features of autoimmunity in the abdominal aortic aneurysm. Arch Surg 1996;131:85-8.
13. Newman KM, Jean-Claude J, Li H, et al. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994;90:II224-7.
14. Shah PK. Inflammation, metalloproteinases and increased proteolysis: an emerging paradigm in aortic aneurysm. Circulation 1997;96:2115-7.
15. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987;65:13-21.
16. Kazi M, Thyberg J, Religa P, et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 2003;38:1283-92.
17. Fontaine V, Jacob M-P, Houard X, et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002;5:1701-10.
18. Kazi M, Zhu C, Roy J, et al. Difference in matrix-degrading protease expression and activity between thrombus-tree and thrombus-covered wall of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2005;25:1-6.
19. Vorp DA, Mandarino WA, Webster MW, Gorcsan J. Potential influence of intraluminal thrombus on abdominal aortic aneurysm as assessed by a new non-invasive method. Cardiovasc Surg 1996;4:732-9.
20. Simao da Silva E, Rodrigues AJ, Magalhaes Castro de Tolosa E, et al. Morphology and diameter of infrarenal aortic aneurysms: a prospective autopsy study. Cardiovasc Surg 2000;8: 526-32.
21. Sakalihasan N, Delvenne P, Nusgens BV, et al. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996;24:127-33.
22. Adolph R, Vorp DA, Steed DL, et al. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg 1997;25:916-26.
23. Busuttil RW, Rinderbreicht H, Flesher A, Carnack C. Elastase activity: the role of elastase in aortic aneurysm formation. J Surg Res 1982;32:214-7.
24. Freestone T, Turner RJ, Coady A, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-51.
25. Newman KM, Jean-Claude J, Li H, et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 1994;20:814-20.
26. Newman KM, Malon AM, Shin RD, et al. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connect Tissue Res 1994;30: 265-76.
27. Tamarina NA, McMillan WD, Shively VP, Pearce WH. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997;122:264-71.
28. Carrell TW, Burnand KG, Wells GM, et al. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002;105:477-82.
29. Jean-Claude J, Newman KM, Li H, et al. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 1994;116:472-8.
30. Northeast ADR, Soo KS, Bobrow LG, et al. The tissue plasminogen activator and urokinase response in vivo during resolution of venous thrombus. J Vasc Surg 1995;22:573-9.
31. Mahmoud M, Gaffney PJ. Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH). Thromb Haemost 1985;53:356-9.
32. Booth NA, Simpson AJ, Croll AM, et al. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988; 70:327-33.
33. Robbie LA, Bennet B, Brown PAJ, et al. Activators and inhibitors of the fibrinolytic system in human thrombi. Thromb Haemost 1996;5:127-33.
34. Robbie LA, Booth NA, Brown PAJ, Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 1996;16:539-45.
35. Adolph R, Vorp DA, Steed DL, et al. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg 1997;25:916-26.
36. Shireman PK, McCarthy WJ, Pearce WH, et al. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta. J Vasc Surg 1997;25:157-64.
37. Reilly JM, Sicard GA, Lucore CL. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg 1994;19:865-72.
38. Woessner JF. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995;248:510-28.
39. Carrell TWG. Fibrinolysis and proteolysis in abdominal aortic aneurysm [thesis]. Cambridge (UK): University of Cambridge; 2004.
40. Anidjar S, Osborne-Pellegrin M, Coutard M, Michel JB. Arterial hypertension and aneurysmal dilatation. Kidney Int Suppl 1992; 37:561-6.
41. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997;17:439-44.